The global crisis of drug-resistant tuberculosis and leadership of China and the BRICS : challenges and opportunities : summary of a joint workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences /

Afficher d'autres versions (1)

Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and 1960s. Since 2008, the Forum on Drug Discovery, Development, and Translation of the Institute of Med...

Description complète

Détails bibliographiques
Cote:Libro Electrónico
Auteurs principaux: Olson, Steve, 1956- (Auteur), English, Rebecca A. (Auteur), Claiborne, Anne B. (Auteur)
Collectivités auteurs: Institute of Medicine (U.S.) (sponsoring body.), Zhongguo ke xue yuan. Wei sheng wu yan jiu suo (sponsoring body.), Global Crisis of Drug-Resistant Tuberculosis and Leadership of the BRICS Countries : Challenges and Opportunities (Workshop)
Format: Électronique Actes de congrès eBook
Langue:Inglés
Publié: Washington, D.C. : The National Academies Press, [2014]
Sujets:
Multidrug-resistant tuberculosis > Congresses.
Multidrug-resistant tuberculosis > Prevention > Congresses.
Tuberculosis > Congresses.
Drug resistance > Congresses.
Multidrug-resistant tuberculosis.
Antitubercular agents.
World health.
International cooperation.
Tuberculosis, Multidrug-Resistant
Antitubercular Agents
Global Health
International Cooperation
Tuberculose multirésistante > Congrès.
Tuberculose > Congrès.
Résistance aux médicaments > Congrès.
Tuberculose multirésistante.
Antituberculeux.
Santé mondiale.
Coopération internationale.
POLITICAL SCIENCE > Public Policy > Social Security.
POLITICAL SCIENCE > Public Policy > Social Services & Welfare.
World health
International cooperation
Antitubercular agents
Drug resistance
Multidrug-resistant tuberculosis
Tuberculosis
China
Congress
proceedings (reports)
Conference papers and proceedings
Conference papers and proceedings.
Actes de congrès.
Accès en ligne:Texto completo
Table des matières:
  • The challenges and opportunities for the BRICS countries to lead
  • Catching up with the microbe
  • Drug-resistant TB in China
  • Experiences with MDR TB in other countries
  • Drug-resistant tuberculosis in pediatric populations
  • Global perspectives on transmission and infection control
  • Rapid diagnostic technologies : status and limitations
  • Addressing diagnosis and treatment across the spectrum of drug resistance
  • Developing and strengthening the drug supply chain for drug-resistant TB
  • Embracing a new vision for research
  • What will be required to achive zero deaths from TB?
  • Creating an evidence-based blueprint for action.

Documents similaires